Literature DB >> 12918070

Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer.

Koji Matsumoto1, Toshiharu Yasugi, Shunsuke Nakagawa, Mitsuo Okubo, Ranko Hirata, Hiroo Maeda, Hiroyuki Yoshikawa, Yuji Taketani.   

Abstract

The enhanced oncogenicity of particular human papillomavirus type 16 (HPV16) E6 variants is population-dependent, implying the involvement of additional genetic cofactors. This study was designed to investigate the association between E6 variants and human leukocyte antigen (HLA) polymorphism within a Japanese population. Fifty-seven women with HPV16-positive cervical cancer were analyzed for E6 sequence variation and its relationship to HLA class II alleles. Compared with local controls (n = 138) and published controls (n = 916), DRB1*1501 and DQB1*0602 frequencies were significantly increased among patients with HPV16 E6 prototype (n = 11). Additionally, DRB1*1502 was positively associated with a particular E6 variant designated D25E (n = 25), although we could not find a significant association between HLA class II alleles and L83V variants (n = 16). Our observations suggest that a specific match between E6 variant proteins and HLA types may contribute to HPV16-related cervical carcinogenesis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918070     DOI: 10.1002/ijc.11332

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China.

Authors:  Qinglong Shang; Yan Wang; Yong Fang; Lanlan Wei; Sijia Chen; Yuhui Sun; Baoxin Li; Fengmin Zhang; Hongxi Gu
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

2.  Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population.

Authors:  Bao-Ying Fei; Bing Xia; Chang-Sheng Deng; Xiao-Qing Xia; Min Xie; J Bart A Crusius; A Salvador Pena
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

3.  Human papillomavirus (HPV) 16 E6 variants in tonsillar cancer in comparison to those in cervical cancer in Stockholm, Sweden.

Authors:  Juan Du; Cecilia Nordfors; Anders Näsman; Michal Sobkowiak; Mircea Romanitan; Tina Dalianis; Torbjörn Ramqvist
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

4.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

5.  HPVMD-C: a disease-based mutation database of human papillomavirus in China.

Authors:  Zhenyu Yang; Wenjing Yi; Jin Tao; Xiaoqing Liu; Michael Q Zhang; Guiqian Chen; Qi Dai
Journal:  Database (Oxford)       Date:  2022-03-26       Impact factor: 4.462

6.  Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.

Authors:  Wei Song; Avima M Ruder; Liangyuan Hu; Yufeng Li; Rong Ni; Wenshuo Shao; Richard A Kaslow; MaryAnn Butler; Jianming Tang
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

7.  Whole genome sequencing and evolutionary analysis of human papillomavirus type 16 in central China.

Authors:  Min Sun; Lei Gao; Ying Liu; Yiqiang Zhao; Xueqian Wang; Yaqi Pan; Tao Ning; Hong Cai; Haijun Yang; Weiwei Zhai; Yang Ke
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

8.  Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer.

Authors:  Patricia S de Araujo Souza; Paulo C Maciag; Karina B Ribeiro; Maria Luiza Petzl-Erler; Eduardo L Franco; Luisa L Villa
Journal:  BMC Cancer       Date:  2008-08-22       Impact factor: 4.430

9.  Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?

Authors:  Koji Matsumoto; Hiroo Maeda; Akinori Oki; Naoyoshi Takatsuka; Toshiharu Yasugi; Reiko Furuta; Ranko Hirata; Akira Mitsuhashi; Kei Kawana; Takuma Fujii; Takashi Iwata; Yasuo Hirai; Masatoshi Yokoyama; Nobuo Yaegashi; Yoh Watanabe; Yutaka Nagai; Hiroyuki Yoshikawa
Journal:  Cancer Sci       Date:  2015-09-25       Impact factor: 6.716

10.  Lineage analysis of human papillomavirus type 39 in cervical samples of Iranian women.

Authors:  Neda Hosseini; Zabihollah Shoja; Arash Arashkia; Amir-Hossein Khodadadi; Somayeh Jalilvand
Journal:  Virol J       Date:  2021-07-22       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.